Piper Sandler Reiterates Overweight on Solventum, Raises Price Target to $110
Benzinga Newsdesk 3 hours ago
Analyst RatingsNewsReiterationPrice Target
Piper Sandler analyst Jason Bednar reiterates Solventum (NYSE:SOLV) with a Overweight and raises the price target from $105 to $110.
Piper Sandler analyst Jason Bednar reiterates Solventum (NYSE:SOLV) with a Overweight and raises the price target from $105 to $110.